Volitionrx (VNRX) EBITDA Margin Growth (3y) (2022 - 2025)
Volitionrx (VNRX) EBITDA Margin Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -184.00 |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 1,505.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -763.00 |
| 10 | Volitionrx | 90,520.94 | -1.03 Mn | - | -928,669.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -928,669.00 |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 1.78 Mn |
| Mar 31, 2025 | 448,065.00 |
| Dec 31, 2024 | 5.68 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.13 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 6.65 Mn |
| Sep 30, 2023 | 77.66 Mn |
| Jun 30, 2023 | 9.59 Mn |
| Mar 31, 2023 | 107.31 Mn |
| Dec 31, 2022 | 2.97 Mn |